Loading...
Loading...
shares gained 11.45% to $21.90 in the pre-market trading session. Roth Capital initiated coverage on Celladon with a Buy rating.
Roundy's, Inc.RNDY shares rose 10.95% to $4.46 in pre-market trading after the company reported stronger-than-expected results for the fourth quarter.
Pharmacyclics Inc.PCYC shares surged 9.87% to $253.22 in pre-market trading after AbbVie
ABBV announced its plans to acquire Pharmacyclics for $261.25 per share in cash and stock.
Navidea Biopharmaceuticals, IncNAVB shares climbed 9.82% to $1.79 in pre-market trading on Q4 results. Navidea Biopharmaceuticals reported a Q3 loss of $0.08 per share on revenue of $2.2 million.
Arrowhead Research Corp. ARWR gained 9.19% to $8.20 in pre-market trading after the company reported the acquisition of Novartis' entire RNAi research and development portfolio and associated assets.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in